| Withdrawn | Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC NCT06592664 | Lisata Therapeutics, Inc. | Phase 1 / Phase 2 |
| Recruiting | The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and NCT07285044 | Mayo Clinic | Phase 2 |
| Not Yet Recruiting | Effects of Aromatherapy with Essential Oils on Anxiety and Depression in Perioperative Patients with Pancreati NCT06833658 | Peking University First Hospital | N/A |
| Recruiting | Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia NCT07359586 | Zhejiang University | — |
| Recruiting | Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematolog NCT07118176 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Recruiting | The Vanguard Study: Testing a New Way to Screen for Cancer NCT06995898 | National Cancer Institute (NCI) | N/A |
| Recruiting | Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula NCT06807437 | SWOG Cancer Research Network | Phase 3 |
| Recruiting | Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer NCT07066995 | Essen Biotech | Phase 1 / Phase 2 |
| Recruiting | A Study of MGC028 in Participants With Advanced Solid Tumors NCT06723236 | MacroGenics | Phase 1 |
| Enrolling By Invitation | Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family Hist NCT06744595 | Mayo Clinic | N/A |
| Recruiting | Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts NCT06271291 | Mayo Clinic | — |
| Recruiting | CEB-01 in Locally Resectable Pancreatic Cancer NCT06538857 | CEBIOTEX | Phase 2 |
| Active Not Recruiting | The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Assoc NCT06115499 | Alliance for Clinical Trials in Oncology | Phase 2 / Phase 3 |
| Recruiting | Use Of Indocyanine Green In Pancreas Surgery NCT06084013 | OHSU Knight Cancer Institute | — |
| Recruiting | A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors NCT06172478 | Daiichi Sankyo | Phase 2 |
| Withdrawn | Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pa NCT04870034 | Roswell Park Cancer Institute | EARLY_Phase 1 |
| Unknown | In This Study, a Retrospective Analysis Was Conducted to Explore the Risk Factors for Patients Undergoing Panc NCT06763250 | luokai zhang | — |
| Active Not Recruiting | A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer NCT06168812 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Recruiting | Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments NCT06799637 | Evopoint Biosciences Inc. | Phase 1 / Phase 2 |
| Not Yet Recruiting | AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic Cancer NCT06080854 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Phase 2 |
| Recruiting | Pancreatic Cancer Detection Consortium NCT06388967 | City of Hope Medical Center | — |
| Terminated | Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pa NCT04965311 | OHSU Knight Cancer Institute | Phase 2 |
| Active Not Recruiting | Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) NCT05642962 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Unknown | Adjuvant Chemotherapy Plus Codonopsis Pilosula Nnannf /Placebo NCT05613465 | Zhejiang Provincial People's Hospital | N/A |
| Recruiting | Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers NCT05497531 | University of California, Irvine | N/A |
| Unknown | Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standa NCT05627427 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Terminated | A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreat NCT05193604 | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Usin NCT06789224 | Lindis Bloodcare GmbH | N/A |
| Recruiting | Pilot Study of Pancreatic Cancer Screening NCT05058846 | University of California, San Francisco | — |
| Completed | Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle A NCT05171517 | Peking Union Medical College Hospital | — |
| Active Not Recruiting | HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics NCT04905082 | City of Hope Medical Center | N/A |
| Unknown | A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up NCT05237193 | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | — |
| Completed | Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced NCT04505553 | University of Washington | Phase 2 |
| Unknown | Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post Surgery NCT05830019 | Shanghai Proton and Heavy Ion Center | N/A |
| Completed | The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gast NCT04602026 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | Clinical Outcomes for Offering Genetic Testing in a Tiered Approach NCT04902144 | Fred Hutchinson Cancer Center | N/A |
| Active Not Recruiting | Comparing Two Methods to Follow Patients With Pancreatic Cysts NCT04239573 | ECOG-ACRIN Cancer Research Group | N/A |
| Unknown | Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic Ca NCT05634564 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Phase 2 |
| Active Not Recruiting | Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal a NCT04147494 | Jonsson Comprehensive Cancer Center | EARLY_Phase 1 |
| Completed | Combined Stent Insertion and HIFU Ablation for Pancreatic Carcinoma With Biliary Obstruction NCT03962478 | Xuzhou Central Hospital | N/A |
| Completed | A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tum NCT03849469 | Xencor, Inc. | Phase 1 |
| Completed | A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) NCT03752398 | Xencor, Inc. | Phase 1 |
| Suspended | Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer NCT03711890 | Ohio State University Comprehensive Cancer Center | N/A |
| Recruiting | Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma NCT03785743 | Tongji Hospital | N/A |
| Completed | Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery NCT03745794 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer NCT03747588 | Peking Union Medical College Hospital | N/A |
| Withdrawn | Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, NCT03563352 | University of Southern California | — |
| Unknown | Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer NCT04082455 | Shanghai Proton and Heavy Ion Center | N/A |
| Unknown | Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tu NCT03302403 | Kang YU | N/A |
| Completed | Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal C NCT03267524 | City of Hope Medical Center | N/A |
| Completed | Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Pancreatic Cance NCT03645148 | Zhejiang Provincial People's Hospital | Phase 1 |
| Terminated | Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Rad NCT03118349 | BioNTech Research & Development, Inc. | Phase 1 |
| Terminated | Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer NCT03137706 | University of Southern California | — |
| Active Not Recruiting | First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide NCT03164486 | Julie L. Sutcliffe, Ph.D | EARLY_Phase 1 |
| Completed | Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline NCT02676349 | Institut de Cancérologie de Lorraine | Phase 2 |
| Terminated | Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1 NCT02687230 | BioNTech Research & Development, Inc. | Phase 1 |
| Unknown | CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor NCT02839954 | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | Phase 1 / Phase 2 |
| Completed | Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies NCT02807844 | Novartis Pharmaceuticals | Phase 1 / Phase 2 |
| Active Not Recruiting | Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy NCT02432963 | City of Hope Medical Center | Phase 1 |
| Completed | Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and NCT02683824 | Stanford University | EARLY_Phase 1 |
| Unknown | Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor NCT02587689 | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | Phase 1 / Phase 2 |
| Completed | Accelerated Recovery Pathway for Discharge After Surgery in Patients With Pancreatic Cancer NCT02517268 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | N/A |
| Completed | Proton and Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer NCT03949933 | Shanghai Proton and Heavy Ion Center | N/A |
| Completed | A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors NCT02009449 | Eli Lilly and Company | Phase 1 |
| Withdrawn | Endoscopic Ultrasound (EUS) Processor Comparison NCT01814631 | AdventHealth | — |
| Completed | Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer NCT01774019 | Boston Scientific Corporation | N/A |
| Unknown | Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume Definition NCT02285660 | The Leeds Teaching Hospitals NHS Trust | N/A |
| Completed | Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive NCT01262040 | Memorial Sloan Kettering Cancer Center | N/A |
| Terminated | A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Pa NCT00907166 | Cornerstone Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy NCT00892736 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced C NCT00423254 | Mannkind Corporation | Phase 1 |
| Suspended | L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN) NCT01330823 | University Medicine Greifswald | Phase 3 |
| No Longer Available | An Expanded Access Program for AM0010 (Pegilodecakin) NCT03554434 | Eli Lilly and Company | — |